These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

172 related articles for article (PubMed ID: 9021174)

  • 1. Clinically used antimicrobial drugs against experimental pneumocystosis, singly and in combination: analysis of drug interactions and efficacies.
    Walzer PD; Runck J; Orr S; Foy J; Steele P; White M
    Antimicrob Agents Chemother; 1997 Feb; 41(2):242-50. PubMed ID: 9021174
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Effect of atovaquone and atovaquone drug combinations on prophylaxis of Pneumocystis carinii pneumonia in SCID mice.
    Comley JC; Sterling AM
    Antimicrob Agents Chemother; 1995 Apr; 39(4):806-11. PubMed ID: 7785975
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Atovaquone compared with dapsone for the prevention of Pneumocystis carinii pneumonia in patients with HIV infection who cannot tolerate trimethoprim, sulfonamides, or both. Community Program for Clinical Research on AIDS and the AIDS Clinical Trials Group.
    El-Sadr WM; Murphy RL; Yurik TM; Luskin-Hawk R; Cheung TW; Balfour HH; Eng R; Hooton TM; Kerkering TM; Schutz M; van der Horst C; Hafner R
    N Engl J Med; 1998 Dec; 339(26):1889-95. PubMed ID: 9862944
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Synergistic combinations of Ro 11-8958 and other dihydrofolate reductase inhibitors with sulfamethoxazole and dapsone for therapy of experimental pneumocystosis.
    Walzer PD; Foy J; Steele P; White M
    Antimicrob Agents Chemother; 1993 Jul; 37(7):1436-43. PubMed ID: 8363372
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Effects of aerosolized synthetic surfactant, atovaquone, and the combination of these on murine Pneumocystis carinii pneumonia.
    Hughes WT; Sillos EM; LaFon S; Rogers M; Woolley JL; Davis C; Studenberg S; Pattishall E; Freeze T; Snyder G; Staton S
    J Infect Dis; 1998 Apr; 177(4):1046-56. PubMed ID: 9534981
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Treatment and prophylaxis of Pneumocystis carinii pneumonia.
    Castro M
    Semin Respir Infect; 1998 Dec; 13(4):296-303. PubMed ID: 9872626
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Drug evaluation of concurrent Pneumocystis carinii, Toxoplasma gondii, and Mycobacterium avium complex infections in a rat model.
    Brun-Pascaud M; Rajagopalan-Levasseur P; Chau F; Bertrand G; Garry L; Derouin F; Girard PM
    Antimicrob Agents Chemother; 1998 May; 42(5):1068-72. PubMed ID: 9593128
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Meta-analysis of prophylactic treatments against Pneumocystis carinii pneumonia and toxoplasma encephalitis in HIV-infected patients.
    Bucher HC; Griffith L; Guyatt GH; Opravil M
    J Acquir Immune Defic Syndr Hum Retrovirol; 1997 Jun; 15(2):104-14. PubMed ID: 9241108
    [TBL] [Abstract][Full Text] [Related]  

  • 9. In-vitro activity of atovaquone, sulphamethoxazole and dapsone alone and combined with inhibitors of dihydrofolate reductase and macrolides against Pneumocystis carinii.
    Cirioni O; Giacometti A; Scalise G
    J Antimicrob Chemother; 1997 Jan; 39(1):45-51. PubMed ID: 9044027
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Comparison of atovaquone (566C80) with trimethoprim-sulfamethoxazole to treat Pneumocystis carinii pneumonia in patients with AIDS.
    Hughes W; Leoung G; Kramer F; Bozzette SA; Safrin S; Frame P; Clumeck N; Masur H; Lancaster D; Chan C
    N Engl J Med; 1993 May; 328(21):1521-7. PubMed ID: 8479489
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Options in the management of pneumonia caused by Pneumocystis carinii in patients with acquired immune deficiency syndrome and intolerance to trimethoprim/sulfamethoxazole.
    Korraa H; Saadeh C
    South Med J; 1996 Mar; 89(3):272-7. PubMed ID: 8604455
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Use of dapsone in the prevention and treatment of Pneumocystis carinii pneumonia: a review.
    Hughes WT
    Clin Infect Dis; 1998 Jul; 27(1):191-204. PubMed ID: 9675476
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Relative potency of 10 drugs with anti-Pneumocystis carinii activity in an animal model.
    Hughes WT; Killmar JT; Oz HS
    J Infect Dis; 1994 Oct; 170(4):906-11. PubMed ID: 7930735
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Treatment of Pneumocystis carinii pneumonia in adults with AIDS.
    Deresinski SC
    Semin Respir Infect; 1997 Jun; 12(2):79-97. PubMed ID: 9195673
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Experimental evaluation of combined prophylaxis against murine pneumocystosis and toxoplasmosis.
    Brun-Pascaud M; Chau F; Simonpoli AM; Girard PM; Derouin F; Pocidalo JJ
    J Infect Dis; 1994 Sep; 170(3):653-8. PubMed ID: 8077724
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Evaluation of the activities of rifabutin combined with atovaquone or low-dose of cotrimoxazole for prevention of pneumocystosis and toxoplasmosis in a dual infection rat model.
    Brun-Pascaud M; Chau F; Rajagopalan-Levasseur P; Derouin F; Girard PM
    J Eukaryot Microbiol; 1996; 43(5):14S-15S. PubMed ID: 8822822
    [No Abstract]   [Full Text] [Related]  

  • 17. [New aspects of epidemiology and treatment of Pneumocystis carinii infection].
    Powierska-Czarny J; Gospodarek E; Czerwionka-Szaflarska M
    Pol Merkur Lekarski; 2004 Nov; 17(101):534-7. PubMed ID: 15754652
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Employment of terbinafine against Pneumocystis carinii infection in rat models.
    Contini C; Colombo D; Cultrera R; Prini E; Sechi T; Angelici E; Canipari R
    Br J Dermatol; 1996 Jun; 134 Suppl 46():30-2; discussion 40. PubMed ID: 8763466
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Structural changes in rat Pneumocystis carinii surface antigens after terbinafine administration in experimental P. carinii pneumonia.
    Contini C; Angelici E; Canipari R
    J Antimicrob Chemother; 1999 Feb; 43(2):301-4. PubMed ID: 11252340
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Guidelines for Prevention of Pneumocystis carinii Pneumonitis in Children and Adolescents with Cancer].
    Groll AH; Ritter J; Müller FM
    Klin Padiatr; 2001 Sep; 213 Suppl 1():A38-49. PubMed ID: 11577363
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.